Updates in Atopic Dermatitis From the European Dermatology Meeting

Updates in Atopic Dermatitis (AD) From the European Dermatology Meeting is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 12/22/2020
Valid for credit through: 12/22/2021

Accreditation:
For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Goal Statement:
The goal of this activity is to educate physicians on current and emerging data from the latest clinical trials and treatment strategies in order to achieve optimal results in patients with moderate to severe atopic dermatitis (AD).

Learning Objectives:
Upon completion of this activity, participants will:
• Have increased knowledge regarding the
? Clinical data surrounding indications in pediatric and adolescent patients for the therapies for moderate to severe AD
? Clinical evidence on emerging targeted treatments for moderate to severe AD
• Demonstrate greater confidence in their ability to
? Incorporate AD treatment strategies that consider patient-specific factors